Clinical Trials Directory

Trials / Completed

CompletedNCT03024229

Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine

The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.

Detailed description

The quality of the renal transplant prior to transplantation is essential for the recovery of graft function in the days following transplantation and its long-term survival. When the kidneys are perfused on perfusion machines before transplantation, the resistance parameters as well as the histological score on the pre-implantation biopsy participate in the evaluation of the quality of the graft. The metabolomic profile of the infusion fluid could provide additional evidence.

Conditions

Interventions

TypeNameDescription
DEVICELifePort® perfusion machineRenal perfusion on LifePort® machine

Timeline

Start date
2017-03-15
Primary completion
2019-09-15
Completion
2020-01-14
First posted
2017-01-18
Last updated
2025-12-23

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03024229. Inclusion in this directory is not an endorsement.